Latest Articles

Publication Date
Ovarian adenomyoma: a case report.

Ovarian adenomyoma is a rare gynecological tumor with a high misdiagnosis rate, leading many patients to undergo unnecessary surgeries that may affect fertility. Menstrual abdominal pain is the most common …

Published: Jan. 6, 2025, midnight
Pfizer’s Depo-Provera contraceptive under fire: Study links it to brain tumor risk - MSN

Pfizer’s Depo-Provera contraceptive under fire: Study links it to brain tumor risk MSN

Published: Dec. 31, 2024, 1:41 p.m.
Nicotinamide Mononucleotide Restores NAD+ Levels to Alleviate LPS-Induced Inflammation via the TLR4/NF-κB/MAPK Signaling Pathway in Mice Granulosa Cells.

Inflammation disrupts the normal function of granulosa cells (GCs), which leads to ovarian dysfunction and fertility decline. Inflammatory conditions such as polycystic ovary syndrome (PCOS), primary ovarian insufficiency (POI), endometriosis, …

Published: Dec. 31, 2024, midnight
DEVELOPMENT OF ENDOSALPINGIOSIS IN PATIENTS WITH A HISTORY OF BREAST CANCER.

Endosalpingiosis occurs in relatively young women. The incidence of endosalpingiosis exceeds that of other diseases affecting female tissues. As endosalpingiosis is a benign tumor, several women with endosalpingiosis are asymptomatic. …

Published: Dec. 28, 2024, midnight
Knowledge of the Benefits and Risks of Oral Contraceptive Use Among Women of Reproductive Age in Western Saudi Arabia: A Descriptive Cross-Sectional Study.

For women of reproductive age, oral contraceptives (OCs) are a well-liked and practical way to control pregnancy. OCs are also used to treat acne, irregular uterine bleeding, and premenstrual syndrome. …

Published: Dec. 26, 2024, midnight
Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment - Frontiers

Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment Frontiers

Published: Dec. 24, 2024, 7:10 p.m.
Prospects for potential therapy targeting immune‑associated factors in endometriosis (Review).

Endometriosis (EM) is a chronic inflammatory disease that is one of the most common causes of gynecological systemic lesions in women before menopause. The most representative histological feature of EM …

Published: Dec. 24, 2024, midnight
Deep learning for endometrial cancer subtyping and predicting tumor mutational burden from histopathological slides - Nature.com

Deep learning for endometrial cancer subtyping and predicting tumor mutational burden from histopathological slides Nature.com

Published: Dec. 21, 2024, 9:20 a.m.
HLA-DMB Correlates With Antitumor Immunity and an Improved Prognosis in Endometrial Carcinoma Tumors - Frontiers

HLA-DMB Correlates With Antitumor Immunity and an Improved Prognosis in Endometrial Carcinoma Tumors Frontiers

Published: Dec. 20, 2024, 4:13 p.m.
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors - Medpage Today

Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors Medpage Today

Published: Dec. 18, 2024, 8:16 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!